Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study
Introduction While use of (hepatitis C virus) HCV-viremic kidneys may result in net benefit for the average end-stage kidney disease (ESKD) patient awaiting transplantation, patients may have different values for ESKD-related health states. Thus, the best decision for any individual may be different...
Guardado en:
Autores principales: | Mark H. Eckman, Adeboye A. Adejare, Heather Duncan, E. Steve Woodle, Charuhas V. Thakar, Rita R. Alloway, Kenneth E. Sherman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1727f86112e64fcc8c0d978602e3eeef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
por: Tuğrul Himmetoğlu, et al.
Publicado: (2007) -
Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients
por: V. Stalin Raj, et al.
Publicado: (2017) -
Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
por: Elsa Gomez-Escobar, et al.
Publicado: (2021) -
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection.
por: Hung-Yin Liu, et al.
Publicado: (2021) -
HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection
por: Monica Basso, et al.
Publicado: (2021)